| scholarly article | Q13442814 |
| P2093 | author name string | Alain Diaz | |
| Ana Marie Landin | |||
| Bonnie B Blomberg | |||
| Daniela Frasca | |||
| Maria Romero | |||
| P2860 | cites work | Inflamm-aging. An evolutionary perspective on immunosenescence | Q28141817 |
| Pandemic versus epidemic influenza mortality: a pattern of changing age distribution | Q28275622 | ||
| TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors | Q42017364 | ||
| Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells | Q43648503 | ||
| Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study | Q43935468 | ||
| Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species | Q44845116 | ||
| Efficacy of sequential annual vaccination with inactivated influenza virus vaccine | Q45832445 | ||
| Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. | Q50595642 | ||
| Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. | Q50619883 | ||
| Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. | Q51989389 | ||
| Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. | Q53555780 | ||
| Age-related loss of naïve T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. | Q54688740 | ||
| Aging and Innate Immunity | Q56986827 | ||
| TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population | Q57243541 | ||
| Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period | Q72332068 | ||
| Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly | Q77436729 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus | Q29619398 | ||
| Influenza vaccination coverage among high-risk groups in 11 European countries. | Q30226483 | ||
| Influenza vaccines provide diminished protection but are cost-saving in older adults. | Q30385909 | ||
| Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine | Q30412266 | ||
| AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans | Q30421821 | ||
| Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians | Q33586253 | ||
| A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. | Q33957993 | ||
| The network and the remodeling theories of aging: historical background and new perspectives | Q34071531 | ||
| Prevalence of high-risk indications for influenza vaccine varies by age, race, and income | Q34126933 | ||
| Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 | Q34129986 | ||
| Mortality benefits of influenza vaccination in elderly people: an ongoing controversy | Q34693675 | ||
| Influenza vaccine responses in older adults | Q34705027 | ||
| Age-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 and CD8 T cell immunity | Q35201154 | ||
| Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans | Q35571149 | ||
| CD28 extinction in human T cells: altered functions and the program of T-cell senescence | Q36121041 | ||
| Antibody response to influenza vaccination in the elderly: a quantitative review | Q36280602 | ||
| Tumor necrosis factor-alpha, biologic agents and cardiovascular risk | Q36283524 | ||
| Inflammation and cardiovascular disease mechanisms | Q36392615 | ||
| Inflammation and neurodegenerative diseases | Q36392630 | ||
| Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans | Q36658296 | ||
| The immune system in extreme longevity | Q36942814 | ||
| A molecular mechanism for TNF-α-mediated downregulation of B cell responses | Q36979267 | ||
| Inflammaging as a major characteristic of old people: can it be prevented or cured? | Q37073898 | ||
| Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine | Q37141069 | ||
| Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3. | Q37172115 | ||
| Cytomegalovirus and human immunosenescence | Q37335339 | ||
| Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response | Q37401759 | ||
| Influenza control in the 21st century: Optimizing protection of older adults | Q37532799 | ||
| Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists | Q37633537 | ||
| Age effects on B cells and humoral immunity in humans | Q37781581 | ||
| Aging affects human B cell responses | Q37841206 | ||
| The aging gut microbiota: new perspectives | Q37852848 | ||
| The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. | Q40474960 | ||
| Down-regulation of CD28 expression by TNF-alpha | Q40781886 | ||
| Immunosenescence and Cytomegalovirus: where do we stand after a decade? | Q41949218 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | TNF | Q18032037 |
| P304 | page(s) | 116-122 | |
| P577 | publication date | 2014-01-15 | |
| P1433 | published in | Experimental Gerontology | Q15766996 |
| P1476 | title | High TNF-α levels in resting B cells negatively correlate with their response | |
| P478 | volume | 54 |
| Q47116886 | Adipose Tissue Inflammation Induces B Cell Inflammation and Decreases B Cell Function in Aging |
| Q38868206 | Ageing and obesity similarly impair antibody responses |
| Q38946555 | Aging of the immune system: Focus on inflammation and vaccination |
| Q38640148 | Aging, cytomegalovirus (CMV) and influenza vaccine responses |
| Q49417741 | An Explorative Biomarker Study for Vaccine Responsiveness after a Primary Meningococcal Vaccination in Middle-Aged Adults |
| Q40214715 | B Cell Activity Is Impaired in Human and Mouse Obesity and Is Responsive to an Essential Fatty Acid upon Murine Influenza Infection |
| Q38636645 | B Cell-Specific Biomarkers for Optimal Antibody Responses to Influenza Vaccination and Molecular Pathways That Reduce B Cell Function with Aging |
| Q88865461 | B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature |
| Q35090929 | B cell function and influenza vaccine responses in healthy aging and disease |
| Q87233122 | B cells shed light on diminished vaccine responses in obesity |
| Q99588597 | Cellular senescence as a potential mediator of COVID-19 severity in the elderly |
| Q35155784 | Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine |
| Q28073431 | Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis |
| Q99344878 | Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia |
| Q47140159 | Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging |
| Q40142973 | Frequencies of peripheral immune cells in older adults following seasonal influenza vaccination with an adjuvanted vaccine |
| Q38890854 | Host Resistance and Immune Aging. |
| Q90136333 | Immunosenescence and human vaccine immune responses |
| Q39310460 | Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection. |
| Q90379883 | Impaired B Cell Function in Mice Lacking Perforin-2 |
| Q36225887 | Inflammaging decreases adaptive and innate immune responses in mice and humans |
| Q35940864 | Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults |
| Q64257625 | Influence of Obesity on Pneumococcus Infection Risk in the Elderly |
| Q97523684 | Kinome profiling of peripheral blood mononuclear cells collected prior to vaccination reveals biomarkers and potential mechanisms of vaccine unresponsiveness in pigs |
| Q91742867 | Metabolic requirements of human pro-inflammatory B cells in aging and obesity |
| Q41445689 | Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes |
| Q35988449 | MicroRNAs miR-155 and miR-16 Decrease AID and E47 in B Cells from Elderly Individuals |
| Q36626088 | Obesity decreases B cell responses in young and elderly individuals |
| Q51767342 | Parallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity. |
| Q39421902 | Senescent B cells in aging and age-related diseases: Their role in the regulation of antibody responses |
| Q36879291 | Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures |
| Q92670282 | The Sleep-Immune Crosstalk in Health and Disease |
| Q40784710 | The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations |
| Q98197071 | The interplay between immunosenescence and age-related diseases |
Search more.